Tech Company Financing Transactions
Function Oncology Funding Round
Function Oncology closed a $28 million Series A financing round on 4/12/2023. Backers included Andreessen Horowitz, Section 32 and Alexandria Venture Investments.
Transaction Overview
Company Name
Announced On
4/12/2023
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Series A
Investors
Proceeds Purpose
The functional genomics platform leverages CRISPR-based gene modulation directly in patient clinical samples, enabling personalized, comprehensive profiling of each patients' tumors to uncover drug target dependencies that cannot be fully identified by conventional genomic profiling. These patient-specific insights may be used to produce tailored treatment strategies and in aggregate will power the development of new therapies against known or novel cancer drivers.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
9880 Campus Point Drive 410
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Undisclosed
Website
Email Address
Overview
Information is everywhere, but understanding is still rare. We aim to deliver not just more data, but differentiated insights about patients and diseases in order to drive better outcomes. The core of our approach is a platform for CRISPR-powered 'personalized functional genomics', which allows efficient, scalable, and individualized assessment of target vulnerabilities directly in clinical samples. For today's patients, this can identify therapeutic opportunities that aren't accessible in any other way. For tomorrow's patients, this powers development of new therapies against critical disease drivers that often hide in plain sight.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Srinath Sampath
Chief Scientific Officer
Srihari Sampath
Chief Technical Officer
Christian Schmedt
Browse more venture capital transactions:
Prev: 4/12/2023: Pitstop venture capital transaction
Next: 4/12/2023: Geneos Therapeutics venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to report on tech company VC transactions. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs